3Sakamoto T,Miyazaki E,Aramaki Y,et al.Improvement of dermatitis by iontophoretically delivered antisense oligonucleotides for interleukin-10 in NC/Nga mice[J].Gene Ther,2004,11(3):317 ～ 324.
4Jeong CW,Ahn KS,Rho NK,et al.Differential in vivo cytokine mRNA expression in lesional skin of intrinsic vs.extrinsic atopic dermatitis patients using semiquantitative RT-PCR[J].Clin Exp Allergy,2003,33 (12):1717 ～ 1724.
5Howell MD,Novak N,Bieber T,et al.Inte.rleukin-10 down regulates anti-microbial peptide expression in atopic dermatitis[J].Invest Dermatol,2005,125(4):738 ～ 745.
6Tazawa T,Sugiura H,Sugiura Y,et al.Relative importance of IL-4 and IL-13 in lesional skin of atopic dermatitis[J].Arch Dermatol Res,2004,295(11):459 ～ 464.
7Bilsborough J,Leung DY,Maurer M,et al.IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis[J].Allergy Clin Immunol,2006,117(2):418 ～ 425.
8Takaoka A,Arai I,Sugimoto M,et al.Involvement of IL-31 on scratching behavior in NC/Nga mice with atopic-like dermatitis[J].Exp Dermatol,2006,15(3):161 ～ 167.
9Takaoka A,Arai I,Sugimoto M,Yamaguchi A,et al.Expression of IL-31 gene transcripts in NC/Nga mice with atopic dermatitis[J].Eur J Pharmacol,2005,516(2):180 ～ 181.
10Watanabe N,Hanabuchi S,Marloie-Provost MA,et al.Human TSLP promotes CD40 ligand-induced IL-12 production by myeloid dendritic cells but maintains their Th2 priming potential[J].Blood,2005,105(12):4749 ～ 4751.
